RecruitingPhase 4NCT04860141

Efficacy of Preoperative Administration of Gabapentin in 3rd Molar Dental Extraction.

Efficacy of Preoperative Administration of Gabapentin in Managing Intraoperative and Postoperative Pain From Third Molar Extractions.

Sponsor

Loma Linda University

Enrollment

98 participants

Start Date

Jun 16, 2021

Study Type

INTERVENTIONAL

Conditions

Pain, Postoperative Dental Pain and Sensation Disorder

Summary

This study is a double-blind, randomized, prospective, placebo-controlled single-center clinical research study in which 600 mg of gabapentin or placebo will be administered 2 hours preoperatively to 49 patients each undergoing wisdom teeth extraction. We will measure intraoperative opioid use, severity of pain, the number of analgesics taken, and side effect profiles (e.g. nausea/vomiting, dizziness) at the following intervals, 4 hour, 8 hour, 12 hour, 24, and 72 hour post-procedure.

Eligibility

Min Age: 18 YearsMax Age: 59 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a drug called Gabapentin 600mg and a drug called Placebo for people with dental pain and sensation disorder and pain, postoperative. The study is currently recruiting participants at 1 location. People eligible for this study include aged 18 Years to 59 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.